NCT07524556Not yet recruiting
Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients
Influance of Walking Fatigability on Spatiotemporal Gait Parameters and Risk of Falling in Patients With Multiple Scalerosis
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This observational study aims to investigate the relationship between walking fatigability, changes in spatiotemporal gait parameters, and risk of falling in individuals with multiple sclerosis (MS). Participants will be divided into two groups: those with walking fatigability and those without. Each participant will undergo functional tests to detect deterioration in patiotemoral gait parameters and risk of falling . The results of this study will help understand how walking fatigability affects gait and fall risk in MS, providing insights for rehabilitation strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 62 (estimated)
- First submitted
- 30 Mar 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Ibrahim Ahmad Elmongy
- Diseases
- Multiple sclerosis
- NCT number
- NCT07524556
What you commit to
- Study type: Observational
- Planned participants: 62
- From 1 Apr 2026 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active MS relapses or corticosteroid treatment within the last 30 days.
Other illness
- The presence of other neurological or orthopaedic conditions that could affect gait or balance.
- Severe cognitive impairment (as determined by clinical history or physician report).
Other
- Visual or vestibular impairments that significantly interfere with gait or postural control.
- Diabetic patients will be excluded as this will interfere with balance.
Who the study is looking for
- Sixty-two RRMS patients from both sexes.
- Aged from 20 to 40 years with a confirmed diagnosis of multiple sclerosis (based on McDonald criteria).
- Ambulatory for at least 6 minutes, without the use of assistive devices.
- EDSS score between 2.0 and 5.0.
- no relapse within 1 month prior to participation
Age in the registry: 20 years to 40 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| multiple sclerosis specialized clinic in the Neurology department, Faculty of Medicine, Alexandria University. Coordinator of this site? Confirm its status | Alexandria | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.